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Janys6, Julia Fricke7,8, Anja Gatzemeier9, Halina Greiser7, Kathrin Günther5, Thomas Illig10, 
Rudolf Kaaks7, Bastian Krone11, Andrea Kühn10, Jakob Linseisen12, Christine Meisinger12,13, 
Karin Michels14, Susanne Moebus11, Alexandra Nieters15, Nadia Obi6, Anja Schultze9, Julia Six-
Merker12,14, Dietmar H. Pieper4 & Frank Pessler1,2,3
We examined acceptability, preference and feasibility of collecting nasal and oropharyngeal swabs, 
followed by microbiome analysis, in a population-based study with 524 participants. Anterior nasal and 
oropharyngeal swabs were collected by certified personnel. In addition, participants self-collected nasal 
swabs at home four weeks later. Four swab types were compared regarding (1) participants’ satisfaction 
and acceptance and (2) detection of microbial community structures based on deep sequencing of 
the 16 S rRNA gene V1–V2 variable regions. All swabbing methods were highly accepted. Microbial 
community structure analysis revealed 846 phylotypes, 46 of which were unique to oropharynx 
and 164 unique to nares. The calcium alginate tipped swab was found unsuitable for microbiome 
determinations. Among the remaining three swab types, there were no differences in oropharyngeal 
microbiomes detected and only marginal differences in nasal microbiomes. Microbial community 
structures did not differ between staff-collected and self-collected nasal swabs. These results suggest 
(1) that nasal and oropharyngeal swabbing are highly feasible methods for human population-based 
studies that include the characterization of microbial community structures in these important 
ecological niches, and (2) that self-collection of nasal swabs at home can be used to reduce cost and 
resources needed, particularly when serial measurements are to be taken.
Due to achievements in molecular and genetic techniques, biological specimens have been collected in epide-
miological studies with increasing frequency during recent years1. Nasal and oropharyngeal swabs are required 
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to examine microbial populations and dynamics of multidrug resistant pathogens (e.g. methicillin-resistant 
Staphylococcus aureus)2–4. However, technical and logistic difficulties may impede collection of such specimens, 
in particular when applied in population-based studies, as there is no immediately apparent benefit for partici-
pating in such studies such as receiving a medical diagnosis or detailed health care advice. Moreover, collecting 
specimens such as oropharyngeal swabs may be less acceptable due to physical discomfort and may thus decrease 
compliance and retention rates in prospective population-based studies.
The German National Cohort (GNC), in German referred to as the NaKo Gesundheitsstudie (http://nako.de), 
is a large population-based prospective study anticipating to recruit about 200.000 participants between 20 and 
69 years of age across 18 study centers, with recruitment for the main study starting in late 20145. The major aims 
of the GNC are to identify risk factors, including lifestyle-related, psychosocial, occupational, and environmental 
factors, for common diseases such as cardiovascular diseases, diabetes, cancer, and neuro-psychiatric, infectious, 
and musculoskeletal diseases. Participants’ microflora will be studied both as exposure variable that might affect 
the risk of common diseases, as an outcome variable modulated by the variables assessed (e.g., nutrition, lifestyle, 
common diseases), and to study dynamics of colonizing microbial populations and selected pathogens in this 
large human population over time. Considering the critical importance of accurate determination of microbiomes 
to address central questions of the GNC, we therefore conducted a feasibility study in Pretest 1 of the GNC, featur-
ing 524 individuals recruited from the general population. The major aims were to (1) test the feasibility (including 
participants’ acceptance and satisfaction) of collecting nasal and oropharyngeal swabs in this population-based 
setting, (2) compare four swab types in the ability to detect microbial community structures at these two anatom-
ical sites, and (3) to test whether equivalent microbial communities could be detected by nasal swabs collected by 
the participants at home compared to nasal swabs collected by trained personnel in the study center.
Results
Figure 1 shows the geographical locations of the six study centers and the type of swabbing conducted at each center.
Preanalytical feasibility. Nasal swabbing at the study center. Nasal swabs were collected from nearly 
all participants in the study centers. Nasal swabs could not be collected from two participants: one participant 
Figure 1. Overview of the participating study centers and swabbing methods applied. Abbreviations used: N 
(staff) = nasal swabs collected by certified personnel in the study center; N (self) = nasal swabs self-collected 
by the participants at home; OP = oropharyngeal swabs collected by certified personnel in the study center. The 
map was taken from: http://commons.wikimedia.org/wiki/Image:Karte_Bundesrepublik_Deutschland.svg and 
edited by the author (MKA). Name of the creator of the source map is David Liuzzo. Link to the license: https://
commons.wikimedia.org/wiki/Commons:Reusing_content_outside_Wikimedia. The map was published under 
the CC Creative Commons Attribution-ShareAlike 2.5 Generic (CC BY-SA 2.5) license, which allows (https://
creativecommons.org/licenses/by-sa/2.5/deed.en): • Share - copy and redistribute the material in any medium 
or format • Adapt - remix, transform, and build upon the material for any purpose, even commercially. • The 
licensor cannot revoke these freedoms as long as you follow the license terms.
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was deemed mentally not competent to understand instructions and purpose of the study (Bremen), whereas 
no reason was given for the other participant (Freiburg). Complete sets of swabs were collected at the other 
study centers (Table 1, third column). The median time for nasal swabbing ranged from one to three minutes. In 
general, only few difficulties were reported by the study personnel (Table 1, fifth column). One participant was 
reported to have “dry mucous membranes” and being “anxious”. Swabs from both nostrils could be obtained from 
all participants except from three: in one case one nostril could not be swabbed because of the presence of nose 
Column 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Nasal swabs collected by study personnel at the study center
Oropharyngeal swabs collected by study personnel at 
the study center
Nasal swabs collected by study 
participants at home













































































































Augsburg 100 100 1 (<1–6) 100 100 100 — — — — — — — — —
Bremen 96 95 3 (1–10) 98 100 100 95 81 (85) 14 (15) 2 (<1–5) 68 (54/79) 94 83 (88) 8 (2–63) 1 (1–13)
Essen 75 75 3 (<1–7) 95 100 100 75 73 (97) 2 (2.7) 2 (1–4) 42 (29/69) — — — —
Freiburg 97 96 2 (1–5) 98 98 100 — — — — — 98 69 (70) 11 (4–44) 1 (1–30)
Hamburg 100 100 2 (<1–5) 98 99 100 100 99 (99) 1 (1.0) 1 (<1–12) 53 (52/99) 100 75 (75) 8 (2–66) 2 (1–30)
Heidelberg 56 56 2 (<1–5) 100 100 98 56 56 (100) 0 (0) 1 (<1–6) 36 (20/56) — — — —
Table 1. Selected feasibility aspects of nasal and oropharyngeal swabbing.
Figure 2. Completeness of oropharyngeal swabbing. The fraction of the anatomical structures swabbed 
successfully was recorded by the certified study personnel in the biosample protocol. Complete swabbing – 
all target structures (tonsils and pharyngopalatine arches bilaterally) could be swabbed; partially successful 
swabbing – the swab touched the mucous membrane of the pharynx in only one spot or only swabbed some 
areas of the pharynx; unsuccessful swabbing - the swab did not touch the oropharyngeal mucous membrane; 
i.e., the swab could not be collected.
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piercing; a reason was not reported in the other two cases. A small fraction of participants reported the urge to 
sneeze and/or sneezing (20%), fewer reported tearing (5.5%); only a few reported pain (0.91%).
Oropharyngeal swabbing at the study center. Between ~85% and 100% of study participants agreed to oro-
pharyngeal swabbing (Table 1, ninth column). Those who refused oropharyngeal swabbing reported “unpleasant 
reaction to oropharyngeal swabbing in the past” as a reason for refusal. The median time needed for oropharyn-
geal swabbing ranged, by study center, from one to two minutes (Table 1, 11th column). Problems or difficulties 
were reported in about half of the oropharyngeal swabs (155/303). The percentage of problems or difficulties 
reported by the study personnel varied between ~36% and ~68%. “Retching” was the main problem reported by 
the participants in all recruitment centers (97%, 149/155), but frank vomiting was not reported. “Defense reac-
tion” was reported in 5.8% (9/155, multiple choice was possible). The completeness of oropharyngeal swabbing 
differed by recruitment center (Fig. 2); all target structures of the pharynx could be swabbed in the majority of 
cases in two centers, but in only about 20% in one of the others.
Nasal self-swabbing at home. The percentage of nasal swabs that were returned to the study center ranged from 
70% to 88% (Table 1, 14th column). In the three study centers participating in this arm of the study, the median 
time from mailing of the swab kit to the participants to self-swabbing was 9.5 days (range, 2 to 66 days). The 
median time from self-swabbing to receipt of the swab at the laboratory was 2 days (range, 1 to 30 days). The study 
participants reported only minor discomfort such as tearing or sneezing when self-collecting the nasal swab. Pain 
at swabbing was reported in only two cases.
Acceptance and preference. All swabbing methods were highly accepted by the study participants (Fig. 3). 
There were only minor differences in acceptance and preference across study centers (Table 2). A considerable 
proportion of participants reported that they would participate in future studies in which collection of nasal or 
oropharyngeal swabs is planned. Participants had no preference regarding who should collect the nasal swab 
(either study personnel or the participant him/herself). Compared to nasal swabs, participants reported less com-
fort when oropharyngeal swabs were collected (Table 1). The participants did not report technical difficulties 
when self-collecting nasal swabs.
Analytical phase. Of the four swab types to be compared, swab 4 (a calcium alginate tipped swab) had to 
be excluded because the stabilizing gel interfered with cell lysis and thus caused DNA extraction problems. The 
following data were therefore obtained with swab types 1, 2 and 3.
Comparison of anterior nasal vs. oropharyngeal microbial communities. The microbial community structure 
analysis of the two tested ecological niches, the human oropharynx and the human anterior nares, revealed the 
presence of 846 phylotypes (PT) (see supplementary Table 1), 46 of which were exclusively found in oropharyn-
geal communities and 164 exclusively in nasal communities (see supplementary Table 2). The communities of 
Figure 3. Acceptance of nasal and oropharyngeal swabbing. Responses to the following 3 statements were 
evaluated using the Likert scale shown in the legend: (1) Collection of the nasal swabs by the study personnel 
was acceptable to me; (2) Collecting the nasal swab at home was acceptable to me; (3) Collection of the throat 
swab by the study personnel was acceptable to me.
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these two habitats differed drastically, forming two separate clusters in the non-metric multidimensional scaling 
(nMDS) plot (Fig. 4). The oropharyngeal communities tended to cluster more tightly together than the nasal 
communities; in agreement with, multivariate dispersion analysis showed that the index of dispersion was higher 
for anterior nasal communities (1.09) than for oropharyngeal communities (0.73). This is in accordance with 
the higher average similarity between all pairs of oropharyngeal communities of 34.8%, compared to only 26.5% 
between all pairs of anterior nasal communities.
The anterior nasal communities were dominated by Actinobacteria (mean abundance of 45% in a total of 195 














Nasal swab collected by study 
personnel
I felt comfortable when the study 
personnel collected the nasal 
swab
5 (1–5) 5 (1–5) 5 (1–5) 5 (1–5) 5 (1–5) 5 (1–5)
I would participate again in a 
study in which a staff member 
collects a nasal swab from me
5 (1–5) 5 (1–5) 5 (1–5) 5 (1–5) 5 (1–5) 5 (2–5)
Oropharyngeal swabs collected by 
study personnel
I felt comfortable when the 
study personnel collected the 
oropharyngeal swab
— 4 (2–5) 4.5 (1–5) — 4.5 (1–5) 5 (1–5)
I would participate again in a 
study in which a staff member 
collects an oropharyngeal swab 
from me
— 5 (1–5) 5 (1–5) — 5 (1–5) 5 (1–5)
Nasal swabbing collected by the 
study participants
I felt comfortable when I collected 
the self-swab at home — 5 (1–5) — 5 (2–5) 5 (1–5) —
I would rather conduct a nasal 
self-swab by myself than having it 
taken by study personnel
— 4 (1–5) — 3 (1–5) 3 (1–5) —
It was easy to collect the nasal 
self-swab — 5 (1–5) — 5 (3–5) 5 (1–5) —
The instructions how to collect 
the self-swab were easy to 
understand
— 4 (1–5) — 5 (1–5) 4 (1–5) —
I would participate again in a 
study in which I self-collect a 
nasal swab
— 5 (1–5) — 5 (2–5) 5 (1–5) —
Table 2. Participants’ acceptance of nasal and oropharyngeal swabbing at the study center (median and 
range). A 5-point Likert scale was used; 1 = strong disagreement, 2 = disagreement, 3 = neither agreement nor 
disagreement, 4 = agreement, and 5 = strong agreement.
Figure 4. Global differences between anterior nasal and oropharyngeal microbial communities. Non-metric 
multidimensional scaling (nMDS) plot of the global bacterial community structure of 195 human anterior nasal 
(triangles) and 118 human oropharyngeal (squares) samples. The phylotype abundances (% sequence reads) 
were standardized but not transformed prior to the use of the Bray-Curtis similarity algorithm.
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Consistent with a previous report by Camarinha-Silva et al.6, the most abundant species were Corynebacterium 
accolens/segmentosum (PT1, 17%), Propionibacterium acnes (PT2, 12%), Staphylococcus epidermidis (PT3, 10%), 
and Staphylococcus aureus (PT5, 8%), which sum up to an average abundance of 47%.
In contrast, the oropharyngeal communities were not dominated by just a few species: the most abundant 
phylotypes (PT15, Leptotrichia sp.; PT12, Fusobacterium periodonticum; PT16, Streptococcus salivarius/vestibula-
ris; PT19, Veillonella atypical; PT20, Prevotella melaninogenica; and PT21, Prevotella histicola) were observed at 
an average abundance of only 3.3–5.1%. Members of five phyla were abundant in the oropharyngeal communi-
ties (38% Firmicutes, 22% Bacteroidetes, 18% Fusobacteria, 11% Actinobacteria and 10% Proteobacteria). Thus, 
the overall microbial community observed here resembles that reported previously for oropharyngeal swabs 
7. Notably, the oropharyngeal communities were richer in species (average number of phylotypes per sample: 
201 ± 41) than the anterior nasal communities (87 ± 37 phylotypes per sample). They also showed higher species 
diversity using both Shannon and Simpson Diversity Indices (H′ = 3.86 ± 0.33 for oropharyngeal vs. 2.17 ± 0.60 
for nasal communities and 1-D = 0.96 ± 0.02 for oropharyngeal vs. 0.76 ± 0.14 for nasal communities) but higher 
species evenness (J′ = 0.73 ± 0.04 for oropharyngeal vs. 0.49 ± 0.11 for nasal communities).
Comparison of swab types 1, 2 and 3. The analysis of diversity indices did not suggest any differences in 
microbial communities when sampling had been performed by each of the three swab types included in this 
analysis (Fig. 5). For instance, Simpson’s Diversity Index of oropharyngeal communities was close to 1 for 
all three swab types; nasal communities had significantly lower diversity indices but, again, there were no 
differences across swab types. Similarly, Analysis of Similarity (ANOSIM) and Permutational Multivariate 
Analysis of Variation (PERMANOVA) gave no evidence for overall differences in the communities detected by 
the different swab types (ANOSIM: global R = 0.001 for nasal and 0.015 for oropharyngal communities while 
PERMANOVA: Pseudo-F = 1.4522, p = 0.131 for nasal and Pseudo-F = 1.4383, p = 0.129 for oropharyngal 
communities).
The abundances of genera detected with each of the three swab types were compared using the Kruskal-Wallis 
test on standardized abundance data of 148 anterior nares and 110 oropharyngeal samples obtained from 258 par-
ticipants. In anterior nares, out of the 95 detected genera only Methylobacterium spp. differed in abundance across 
swab types in that it was more frequently detected with swab 2 (p = 0.0077, Fig. 6). In oropharynx all genera were 
detected with equal frequency by all three swab types.
Comparison of staff-collection vs. self-collection at home of anterior nasal swabs. We then tested whether, for the 
purpose of microbiome determination, nasal self-swabbing at home is as suitable as swabbing by the certified 
personnel in the study centers. The communities of 54 nasal swabs self-collected by the participants at home 
were compared to 54 age and sex matched staff-collected swabs taken at the study centers. As observed above 
in the comparison of the three swab types, there were no differences in the overall communities (ANOSIM: 
global R = 0.019, PERMANOVA: Pseudo-F = 1.909, P = 0.061) nor were there any differences in diversity indices 
between the self-collected and the staff-collected swabs. Only members of the genus Lactobacillus were distrib-
uted differentially (p = 0.0222; Fig. 7).
Discussion
This is the first study that formally examined acceptance and feasibility of nasal and oropharyngeal swabbing in a 
multicenter population-based epidemiological study, and coupled this with detailed characterizations of micro-
bial communities in these two ecological niches of great importance to human health.
Feasibility of integrating anterior nasal microbiome analyses into population-based stud-
ies. As expected, acceptance of nasal swabbing by both study personnel and study participants was very high in 
all study centers, and the short time required for swab collection and processing is well within the range that can be 
easily integrated into large human studies. Of note, our results also clearly show the equivalence of staff-collected 
and self-collected nasal swabs. In particular, the data demonstrate the robustness of microbiome determinations 
from nasal swabs to differences in temperature after collection when RNAlater is used as a preservative: whereas 
the staff-collected swabs were frozen shortly after collection, the self-collected swabs were not frozen until receipt 
in the study center (usually 1 or 2 days after collection). The observed high feasibility of nasal self-swabbing at 
home agrees well with previous results obtained in somewhat different settings, where self-collection of nasal swabs 
was found to be feasible for capturing viral pathogens causing acute respiratory infections8–11 and for the serial 
determination of S. aureus colonization in a population-based setting2. Self-swabbing is a highly cost-effective 
method, particularly when serial swabs are to be collected, which would normally require multiple visits to the 
study center. Our data indicate that it can be used as an alternative to staff-collection in population-based studies 
featuring NGS-based analyses of anterior nasal microbiomes (next-generation sequencing).
Particular aspects of oropharyngeal swabbing. There is a common opinion that oropharyngeal swab-
bing might have negative effects on acceptance and compliance in prospective population-based studies due to 
the difficulties of the swabbing procedure in this anatomical location, and that this may result in poor response 
rates and/or high attrition rates. The observed high acceptance of oropharyngeal swabbing by the participants and 
their stated willingness to participate in future studies featuring oropharyngeal swabbing suggest that this may 
not be the case, at least if swabbing is performed by trained personnel (as was the case in our study). Nonetheless, 
despite the training provided to the study personnel before study start, completeness of oropharyngeal swabbing 
(as measured by the fraction of the anatomical structures swabbed successfully) varied among the study centers, 
and the degree of participants’ discomfort was clearly higher than in the case of nasal swabbing. Thus, particular 
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attention should be paid to training study personnel in technique that aims to maximize completeness of swab-
bing of oropharyngeal structures, while minimizing discomfort.
Microbiological validation. The microbial community structure analyses largely agree with previous studies 
of anterior nasal and oropharyngeal microbiomes, thus underscoring the microbiological validity of our approach. 
Of note, despite the difficulties encountered with oropharyngeal swabbing discussed above, representative 
Figure 5. Community diversity in anterior nares and oropharynx according to swab type. The species richness, 
Shannon diversity index (H′), Simpsons diversity index (1-D), and Pielou’s evenness index of communities 
collected by three different swabs (swab 1, flocked nylon swab; swab 2, rayon swab; swab 3, polyurethane tipped 
swab) are shown. The whiskers of the plots indicate 10–90 percentiles. The number of swabs analyzed were 54 
(swab 1), 52 (swab 2) and 44 (swab 3) nasal swabs and 39 (swab 1), 34 (swab 2) and 37 (swab 3) oropharyngeal 
swabs. There was no statistically significant difference in the diversity observed in communities obtained with 
the different swabs, whereas communities taken from the nares or the oropharynx were significantly different 
(p < 0.0001).
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microbial communities were detected with nearly all oropharyngeal swabs, underscoring the analytical robustness 
of this method. The swab comparison showed that all three swab types included in the laboratory analyses are 
suited equally well for determination of nasal and oropharyngeal microbiomes in population-based settings. This 
is particularly important because the choice of swab may vary among future studies in other locations; our data 
suggest that comparability of data should be good if one of these three swab types is used.
Limitation of the study. Due to the design of the Pretest 1 studies across all study centers, it was not 
possible to apply culture-dependent microbiological methods at the time of swabbing, and we therefore do 
not have data from this classical approach about the presence of lead organisms such as Streptococcus spp. and 
Staphylococcus spp. in parallel with the NGS-based microbiome data.
Conclusions. Nasal and oropharyngeal swabbing turned out to be highly accepted and feasible methods to 
collect NGS-based data on bacterial microbiomes in these two ecological niches in population-based studies. 
Figure 6. Relative abundance of selected genera in anterior nasal microbial communities according to swab 
type. Shown are those genera that either were the most abundant or showed a statistically different abundance 
across swab types (indicated as 1, 2 and 3, respectively; see Methods for details about the swabs). **p < 0.01 
(Kruskall-Wallis test with post-test Dunn’s). The horizontal lines indicate median values.
Figure 7. Relative abundance of selected genera in nasal microbial communities. The method of swab 
collection is indicated on the x-axis: collected in the study center = C; collected at home = H. Only samples 
that had a perfect match in participant age and sex were considered (54 samples each). Statistically significant 
differences in genus abundances between samples taken at home by study participants (H) and by certified 
study personnel at the study center (C) were calculated by the Mann Whitney U test, *p < 0.05; ***p < 0.001. 
Median values are indicated by the horizontal lines.
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They can thus be used in larger-scale population-based studies on nasal and oropharyngeal microbiomes and 
their effects on health and disease of the host.
Methods
Study population. The study was integrated into the Pretest 1 phase of the GNC, which was conducted in 
2011 and aimed to test the feasibility of a variety of aspects of recruitment, assessments and examinations in the 
study center, and follow-up12–14. All study centers drew random population-based samples from the respective 
residents’ registration offices. In brief, invitations were sent out by mail and included a description of the aims 
and examination procedures of the study and a copy of the approval letter from the data protection commis-
sioner. A reminder letter was sent if there was no response after four weeks. Individuals were additionally con-
tacted by phone, if a phone number was available. Out of the 17 centers participating in Pretest 1, the feasibility 
of obtaining nasal and oropharyngeal swabs was tested in six and four study centers, respectively. Three of these 
study centers also examined the feasibility of obtaining self-collected nasal swabs at home. Fig. 1 shows the geo-
graphical locations of the six study centers and the type of swabbing conducted at each center. All participants 
in Pretest 1, and thus the presented feasibility study, also participated in a basic face-to-face interview to obtain 
commonly assessed demographic, socioeconomic and medical data, in anthropometric measurements (height 
and weight), heart rate and blood pressure measurements, the collection of other biosamples, and in other fea-
sibility studies.
Nasal and oropharyngeal swabbing. Training of study personnel. The local study teams consisted of 2-4 
individuals (both physicians and study nurses) and were trained and certified on site by the coordinator of the 
presented study, who is a licensed physician and has extensive personal experience in obtaining nasal and pharyn-
geal swabs according to internationally accepted Standard Operating Procedures (SOPs). Training sessions con-
sisted of three parts: (a) a Powerpoint presentation (reviewing the aims of the study, relevant anatomy, sampling 
technique and sample preservation), (b) demonstration and hands-on training, and (c) certification (each trainee 
had to demonstrate three correctly executed swabs).
Swabbing procedure. In the study center, the certified personnel explained the study aims to the participant and 
then collected from him/her one anterior nasal swab from each nostril and one oropharyngeal swab. For nasal 
swabbing, the swab was inserted into the nostril to a depth of 1–1.5 cm and rotated three times on the nasal lining 
under constant pressure. This procedure was repeated for the other nostril. Both swabs were then placed into 
one 1.5 ml storage tube (Micro tube, Sarstedt, no. 72.694.005) containing 1 ml RNAlater® Stabilization Reagent 
(QIAGEN, Austin, Texas, USA). Furthermore, the study personnel swiped the oropharyngeal swab over the ton-
sils (or “tonsillar areas” if tonsils were atrophied or had been removed) and pharyngopalatine arches bilaterally. 
The fraction of these anatomical structures that was swabbed successfully was recorded in the biosample protocol 
and was used as a proxy for completeness of the pharyngeal swabbing procedure. After completing the swabbing 
procedure, the swab tip was clipped off and placed in a 1.5 ml storage tube containing 1 ml RNAlater®. After col-
lection, the swabs were placed on dry ice and transferred to −80 °C storage by the end of the day.
Lastly, in three study centers (Fig. 1), the participants were instructed how to self-collect nasal swabs. Four 
weeks later, a swabbing kit containing two nasal swabs, a transport tube containing 2 ml RNAlater, a small bottle 
containing 2 ml NaCl, a questionnaire, instructions how to self-collect a nasal swab, and gloves were sent to the 
participants. They were asked to self-collect one nasal swab from each nostril, complete a questionnaire and mail 
everything to the laboratory within 24 h. The swabbing procedure at home was described in a manner similar to 
that in the study center. In brief, the nasal swab was to be inserted into the nostril to a depth of approx. 1.5 cm, 
rotated three times on the nasal lining under constant pressure and placed into RNAlater. The participants were 
instructed to keep the swabs in the refrigerator overnight if they were collected the day before shipping. The swabs 
were shipped at ambient temperature and placed at −80 °C upon arrival in the study center.
Swab types. The following four swab types were compared: swab 1–flocked nylon swab (Nr. 502CS01, Hain 
Lifescience), swab 2–rayon swab (Nr. 30MW112, Check Diagnostics GmbH), swab 3–polyurethane tipped swab 
(Nr. 30MW940/125, Check Diagnostics GmbH), and swab 4–calcium alginate tipped swab (Nr. 25-806 1 Pa, 
Check Diagnostics GmbH). The study participants were randomized by block randomization to one of the four 
swab types. In a given participant, the same swab type was used for nasal and oropharyngeal swabbing and for 
nasal self-swabbing.
Acceptance. After completing the swabbing procedure, the participants were asked to fill in separate accept-
ance questionnaires for nasal and oropharyngeal swabbing at the study center and nasal self-swabbing at home. 
Acceptance was assessed with questions on a five-point Likert scale. Participants rated each item with 1 (strong 
disagreement), 2 (disagreement), 3 (neither agreement nor disagreement), 4 (agreement), or 5 (strong agree-
ment). Some of the items were reverse-phrased to reduce response bias.
Laboratory analysis. Out of the 1807 swabs collected, a subsample of 313 swabs (195 nasal and 118 oro-
pharyngeal swabs, originating from 258 participants) was selected for microbiome analysis, as this number was 
deemed large enough to achieve the major goals of the study (Table 3, supplemental Table 3). To avoid any pos-
sible bias introduced by incorporating multiple swabs from the same participant, only 258 swabs (148 samples 
from the anterior nares and 110 oropharyngeal samples, see Table 3 and supplemental Table 3) were analyzed for 
comparing swab types or self-swabbing vs. swabbing by trained personal. Separate swabs were collected from 
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each nostril, but only one of the two swabs was randomly taken for analysis, resulting in a random mixture of 
swabs from the left or the right nostril for subsequent analyses.
Swabs were placed into tubes containing 500 µl nuclease-free H2O and 100 mg of glass beads 
(acid-washed, ≤ 106 µm, Sigma-Aldrich). Cells were lysed in a FastPrep®-24 Instrument for 30 seconds at an 
intensity setting of 6. DNA extraction was performed using the InstaGene Matrix (Biorad) following the man-
ufacturer’s instructions. Amplicon libraries were generated of the V1–V2 region of the 16 S rRNA gene using 
the primers 27 F and 338R6 in a 20 cycle PCR reaction as previously described8. Amplicons were extracted 
from agarose gels with the help of Qiagen’s QIAquick Gel Extraction Kit according to the manufacturer’s pro-
tocol. Before sequencing, the concentration of the cleaned-up PCR products was quantified with the Quant-iT 
PicoGreen dsDNA Kit (Invitrogen) and samples were pooled in equal concentrations. Sequencing of 2 × 250 bp 
was performed on an Illumina MiSeq Sequencer (Illumina, Hayward, Californa, USA). Raw sequences were 
merged15 and subsequently aligned using MOTHUR (gotoh algorithm with the SILVA reference database) prior 
to pre-clustering, allowing two mismatches. A total of 14.5 million sequences for 313 samples (46,399 ± 28,247 
sequences per sample) were analyzed. Only phylotypes with an average abundance of at least 0.001% of the total 
communities and a sequence length of >200 bp were considered for follow-up analysis. All phylotypes were 
assigned a taxonomic affiliation based on naïve Bayesian classification (RDP classifier)16. Phylotypes were then 
manually analyzed against the RDP database using the Seqmatch function as well as against the NCBI database 
to define the discriminatory power of each sequence. Sequences not originating from 16 S rDNA were deleted, 
leaving a total of 13.2 million sequences. The minimal number of reads per sample was 8850. A species name 
was assigned to a phylotype when only 16 S rRNA gene fragments of previously described isolates of that species 
showed ≤2 mismatches with the respective representative sequence read. Similarly, a genus name was assigned 
to a phylotype when only 16 S rRNA gene fragments of previously described isolates belonging to that genus and 
of 16 S rRNA gene fragments originating from uncultured representatives of that genus showed ≤ 2 mismatches. 
Relative abundances of bacterial phyla or phylotypes were then determined by summing up all sequences and 
calculating the relative share of each phylum/phylotype to the whole microbial community.
Statistical analysis. All analyses were computed on standardized abundance data. Sample-resemblance matri-
ces were calculated on the basis of the Bray-Curtis algorithm17. Bacterial community structures of a priori defined 
groups were visualized by ordination using nMDS with 50 random restarts. Significant differences between a priori 
predefined groups of samples were evaluated using Analysis of Similarity (ANOSIM) (9999 permutations) with the 
accompanying R statistic measuring the degree of separation between groups18 and/or permutational multivariate 
analysis of variance (PERMANOVA), allowing for type III (partial) sums of squares with a fixed effects sum to zero 
for mixed terms and exact p-values generated using unrestricted permutation of raw data19. Groups of samples 
were considered significantly different if the p-value was <0.05. The degree of intra-variation for samples from the 
same habitat was calculated by applying multivariate dispersion analysis, where a low dispersion index indicates low 
within-group heterogeneity. Phylotype richness, diversity, and evenness were explored by calculating total phylo-
types (S), Simpson’s Diversity Index (1-D), Shannon Diversity Index (H′) and Pielou’s Evenness Index (J′) on sub-
sampled data using the function rarefy_even_depth (rngseed = TRUE) from the R package “phyloseq”20.
The abundances of species-of-interest and univariate diversity indices were compared between a priori groups 
of samples using either a t-test or analysis of variance (ANOVA). Species abundance data and diversity indices 
were subjected to a normality test using both the D’Agostino & Pearson omnibus and the Shapiro-Wilk algo-
rithms (Prism 6, Graphpad Software Inc). Since most of the PT abundances across most of the groups returned 
estimates indicating non-normal distributions, the Kruskal-Wallis test with Dunn’s multiple comparison post-hoc 
test was used when multiple groups were being compared, whereas the Mann-Whitney test was used when only 
2 groups were compared. The Benjamini-Hochberg correction was applied for multiple comparisons21. Groups 
of samples were considered significantly different if the p-value was <0.05. The multivariate analyses were per-
formed and diversity indices were calculated using PRIMER (v7.0.6; PRIMER-E; Plymouth Marine Laboratory, 
UK)18 whereas the univariate analyses and normality tests were performed in Prism 6 (Graphpad Software, Inc.).
Ethics approval. All procedures performed in studies involving human participants were in accordance with 
the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki decla-
ration and its later amendments or comparable ethical standards. The study was approved by the responsible 
ethics committees of the German Federal States in Augsburg, Bremen, Essen, Freiburg, Hamburg and Heidelberg. 
Informed consent was obtained from all individual participants included in the study.
Nasal swabs collected by certified 
personnel at the study center
Oropharyngeal swabs collected by 
certified personnel at the study center
Nasal swabs collected by study 
participants at home
Swab type swab1* swab2** swab3*** swab1* swab2** swab3*** swab1* swab2** swab3***
No. of swabs 23 26 25 39 34 37 31 26 17
Total no. of 
swabs analyzed 74 110 74
Table 3. Overview of swabs included in the microbiome analysis. 313 samples originating from 258 individuals 
were analyzed. To avoid possible bias, a subset of analyses was performed on 258 samples comprising only one 
swab per individual. *Swab 1 – flocked nylon swab. **Swab 2 – rayon swab. ***Swab 3 – polyurethane tipped 
swab. Swab 4 (calcium alginate) was excluded because it had proven unsuitable during preanalytical processing 
(see Results).
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